Navigation Links
InNexus Biotechnology Completes Preclinical Study Confirming in Vivo Effectiveness and Safety of Lead Candidate DXL625, Schedules Meeting With FDA
Date:1/13/2009

BRITISH COLUMBIA, Canada, Jan. 13 /PRNewswire-FirstCall/ -- InNexus Biotechnology Inc., (OTC Bulletin Board: IXSBF; TSX VENTURE: IXS; http://www.ixsbio.com), a drug development company commercializing the next generation of monoclonal antibodies based on its Dynamic Cross Linking (DXL(TM)) technology, announces the completion of a large scale primate study confirming effectiveness and safety of its lead candidate DXL625 (CD20). The Company also announced that it has scheduled a meeting with the United States Food and Drug Administration (FDA) during the first half of 2009 to discuss the design of a clinical study.

"This study confirms that DXL625 is specific to the CD20 antigen present on NHL tumor cells and is a major milestone in our plan for clinical and commercial success," said Jeff Morhet, CEO and Chairman of InNexus. "This success paves the way for the filing of an IND and commencement of clinical trials of DXL625 in the near future." Complete results from this study are being compiled and will be presented at the annual scientific meeting of the American Association for Cancer Research (AACR) this spring.

InNexus' recently completed study was designed to confirm DXL625's in vivo safety and efficacy. The candidate was effective in completely eliminating all lymphocytes with a CD20 marker within hours at the lowest dose tested. No adverse events were seen even at a dose 100-fold higher than the lowest dose. The CD20 marker is the same as that found on tumors cells in patients with Non-Hodgkins Lymphoma patients. Previous studies have shown that DXL625 has greater potency as compared to existing therapeutic antibodies.

Pre-clinical data show that DXL625 has a safety profile equal to Rituxan(R) when evaluated in the same validated model. The preclinical study was conducted with a single injection, which confirms the remarkable potency
'/>"/>

SOURCE InNexus Biotechnology Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. InNexus Biotechnology Announces Third Antibody and Expands Pipeline of Anticancer Compounds
2. Accuray Incorporated Ranked Fifth in Deloittes Technology Fast 50 Program for Silicon Valley Scientific/Medical Equipment, and Biotechnology Companies
3. Malaria Vaccine Developer Sanaria Inc. and the University of Maryland Biotechnology Institute Awarded Collaborative, Multi-Year, US $600,000 NIH Phase I Small Business Innovation Research Grant
4. Haemacure to Present at the BioInternational Convention - The Global Event for Biotechnology - at the San Diego Convention Centre, California, from June 17 - 20, 2008
5. CuraGen to Present at The Seventh Annual Needham & Company Biotechnology and Medical Technology Conference
6. Cline Davis & Mann Launches Platform Advisors(TM), a New Division to Provide Integrated Strategic and Scientific Consulting Services for the Pharmaceutical, Biotechnology, and Medical Device Industry
7. NeurogesX to Present at the Seventh Annual Needham & Company Biotechnology and Medical Technology Conference
8. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the Seventh Annual Needham & Company, LLC Biotechnology and Medical Technology Conference on June 11, 2008 in New York
9. BeaconEquity.com Issues TraderNotes on Biotechnology Stocks: TPIM, RXII, VION, CUR, AMGN, GILD, BIIB, GENR
10. Genetic Engineering and Biotechnology News reports on early ADMET use
11. China Medicine Corporation Selected to Represent Biotechnology Industry of Guangzhou City at 2008 Annual BIO International Convention

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)..., BC, Nov. 27 /PRNewswire/ - Uploadable USB pedome...time in wellness. A combination of advanced accele...e solving a long term concern over the accuracy of...ly gauge and reward improved participation in a fi...e of the first wellness suppliers to integrate thi...
(Date:11/27/2009)..., Nov. 27 Considered a ...nly 25 years ago, solid organ transplantation is n...e extraordinary men and women who gathered at the ... came together from medical centers around the wor...ional Transplant Institute (BRTI), one of the pion...
(Date:11/27/2009)...TER, N.Y., Nov. 27 Prev...ovider and fortunately every year, new vaccines ar... do all vaccines boost immunity for the same perio...er shots, needed to keep immunity strong? ,, ...f the American Academy of Pediatrics, Michael Pich...
(Date:11/27/2009)... SHAMIR, Israel, Nov. 27 ...Shamir" ), a leading provider of innovative produc...nnounced today that its board of directors had dec...nt of US$ 10 million (approximately NIS 37.62 mill...rate of exchange), or approximately US$ 0.609 (app...
(Date:11/27/2009)...g plus low-emission vehicles may reduce future dis... Nov. 27 (HealthDay News) -- Encouraging city dwel...ld offer much greater public health benefits than ...archers have found. , The study compared the pr...n land transport scenarios for London, England, an...
Breaking Medicine News(10 mins):Health News:New USB technology adds accountability and convenience to wellness programs 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 3Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:More Foot Power, Less Car Pollution Best for Health 2
...ation (FDA) is urgently reminding the public that ...h risk to infants//, small children, and adults wi...hosts to Salmonella, a group of bacteria that can ...und in a pet turtle in the home. Salmonella...
... has come out with a possible herbal cure for urin... team from the Duke University Medical Center fo...wn as the Indian Coleus plant, can significantly r...earinghouse (NKUDIC) says urinary tract infections...
...rs old. It claims to be the world's oldest inhabit...// East. Its population of 1.74 millions is s...in a country where water is a scarce commodity, wh...x. It is a shrub whose leaves, when you chew them,...
...been finally banned in China. It has banned organi...ns //in any form. This regulation will be effectiv...s about 5,000 transplants; mostly kidneys every ye...prisoners and transplanting them to foreigners. Th...
... greater risk of developing colon cancer, the thir... The fat cells in the body of obese people produc... grow faster. The more fat cells a person has, the...us growths in the colon, rectum and appendix. ...
... economically advanced among the other backward cl... educational quota policy as the government prepar...stay on the new policy. "My team of lawyers wi...waj told a section of the United Progressive Allia...
Other Medicine News:Health News:FDA Re-Emphasizes Warnings to Consumers on Risks of Pet Turtles 2Health News:Ancient Indian Herb May Prove Cure For Recurrent UTI 2Health News:Drug Uses Up Water in Yemeni Capital, People Must Relocate 2Health News:Ban on Trade of Human Organs in China 2Health News:OBC Creamy Layer May Be Dropped from Reservations in Institutions 2Health News:OBC Creamy Layer May Be Dropped from Reservations in Institutions 3
(Date:11/25/2009)...HO CORDOVA, Calif., Nov. 25 AMPAC ... Pacific Corporation (Nasdaq: APFC ) announced to...ity and Sustainability Award at the Annual Statewi...ia Manufacturers and Technology Association (CMTA)...nd the Chemical Industry Council of California (CI...
(Date:11/25/2009)... CITY, Calif., Nov. 25 A...ompany manufacturing point-of-care blood analysis ...rman and chief executive officer, will present at ...ce on Wednesday, December 2, 2009 at 2:00 p.m. ET....e Hotel in New York City. ,, About Abaxis ,...
(Date:11/25/2009)..., NEW YORK, Nov. 25 Reportlinker.c...available in its catalogue: ,, Pain Managemen....com/p0164220/Pain-Management---Global-Trends.html...emergence of pain management clinics, and the adve...h in the pain management market. Healthcare reform...
Breaking Medicine Technology:AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 2AMPAC Fine Chemicals Receives Prestigious Award at California's Annual Statewide Environmental Summit 3Reportlinker Adds Pain Management - Global Trends 2Reportlinker Adds Pain Management - Global Trends 3Reportlinker Adds Pain Management - Global Trends 4Reportlinker Adds Pain Management - Global Trends 5Reportlinker Adds Pain Management - Global Trends 6Anticancer compound found in American mayapple 9798 1Anticancer compound found in American mayapple 9798 2For peats sake 3A Alternative growing media 9796 1For peats sake 3A Alternative growing media 9796 2Biophysical Society Announces 2010 society fellows 9794 1
...el includes data showing 35% reduction in new clin...following a recent hip ...osteoporosis treatment following hip fractu...,- Safety and efficacy profile of Reclast, already...eoporosis(1), reinforced in revised label, EAST H...
... N.Y., June 4 Ion-channel research is,drawing inc...nce,investigators all over the globe, reports Gene... interest is not surprising as ion channels,play k...neural signal,transduction, cardiac, skeletal, and...rt of nutrients and ions, among others, according ...
Other Medicine Technology:FDA Broadens US Indication for Once-Yearly Reclast(R) as Only Osteoporosis Treatment Approved for Prevention of Fractures After a Hip Fracture 2FDA Broadens US Indication for Once-Yearly Reclast(R) as Only Osteoporosis Treatment Approved for Prevention of Fractures After a Hip Fracture 3FDA Broadens US Indication for Once-Yearly Reclast(R) as Only Osteoporosis Treatment Approved for Prevention of Fractures After a Hip Fracture 4FDA Broadens US Indication for Once-Yearly Reclast(R) as Only Osteoporosis Treatment Approved for Prevention of Fractures After a Hip Fracture 5FDA Broadens US Indication for Once-Yearly Reclast(R) as Only Osteoporosis Treatment Approved for Prevention of Fractures After a Hip Fracture 6FDA Broadens US Indication for Once-Yearly Reclast(R) as Only Osteoporosis Treatment Approved for Prevention of Fractures After a Hip Fracture 7Genetic Engineering & Biotechnology News Reports on the Growing Role of Ion-Channel Studies in Global Biotech R&D 2
...revolutionary MiniQuad, the DynaView 156 is design...ding to the ora serrata in both premature infants ...nd reduced 8.5mm contact element, the Volk DynaVie...rgery and is an absolute requirement for lens spar...
Iridectomy
... Super Macula® 2.2 offers extremely high resol...ea, while achieving an exceptionally wide 78° ...r critical evaluation of the optic nerve head and ... the macula and disc. Redesigned to reduce weight ...
...quator is designed for focal laser therapy and mid...tical design presents a realistic contour of the r...d view of the entire posterior pole extending to t...s dynamic movement on the globe, therefore increas...
Medicine Products: